Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Evofem Biosciences Inc (ID) EVFM

Healthcare Biotechnology
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. The company’s commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences... see more

Recent & Breaking News ()

Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE

PR Newswire November 21, 2025

Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update

PR Newswire November 13, 2025

Evofem Announces Voting Results from Special Meeting of Stockholders

PR Newswire October 20, 2025

Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates

PR Newswire October 1, 2025

Evofem Biosciences Honors World Contraception Day

PR Newswire September 26, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLNK, BFIN, MRCC, EVFM on Behalf of Shareholders

GlobeNewswire September 11, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - EVFM, MRCC, MLNK, and BFIN

GlobeNewswire September 11, 2025

Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms

PR Newswire September 11, 2025

Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting

PR Newswire September 9, 2025

Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law

PR Newswire August 21, 2025

FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis

PR Newswire August 19, 2025

Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update

PR Newswire August 14, 2025

Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference

PR Newswire August 5, 2025

Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy

PR Newswire July 15, 2025

Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store

PR Newswire June 23, 2025

Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting

PR Newswire June 11, 2025

Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1

PR Newswire May 21, 2025

Evofem Reports First Quarter 2025 Financial Results and Provides Business Update

PR Newswire May 15, 2025

Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates

GlobeNewswire April 15, 2025

Evofem Biosciences to Present at Emerging Growth Conference

PR Newswire April 14, 2025